Market Newsdesk

January 27, 2025 5:49 am

Lost Money on Joint Stock Company Kaspi.kz(KSPI)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm

PR Newswire

NEW YORK
, Jan. 27, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Joint Stock Company Kaspi.kz (NASDAQ: KSPI).

Shareholders who purchased shares of KSPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/joint-stock-company-kaspi-kz-loss-submission-form/?id=124871&from=4

CLASS PERIOD:
January 19, 2024 to September 19, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Joint Stock Company Kaspi.kz continued doing business with Russian entities, and also providing services to Russian citizens, after Russia’s 2022 invasion of Ukraine, thereby exposing the Company to the undisclosed risk of sanctions; (2) the Company engaged in undisclosed related party transactions; (3) certain of the Company’s executives have links to reputed criminals; and (4) as a result, defendants’ statements about Joint Stock Company Kaspi.kz’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

DEADLINE: February 18, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/joint-stock-company-kaspi-kz-loss-submission-form/?id=124871&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of KSPI during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is February 18, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/lost-money-on-joint-stock-company-kaspikzkspi-join-class-action-suit-seeking-recovery–contact-the-gross-law-firm-302359952.html

SOURCE The Gross Law Firm

January 27, 2025 5:49 am

The Gross Law Firm Reminds Symbotic Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 3, 2025 – SYM

PR Newswire

NEW YORK
, Jan. 27, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Symbotic Inc. (NASDAQ: SYM).

Shareholders who purchased shares of SYM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/symbotic-loss-submission-form-2/?id=124863&from=4

CLASS PERIOD:
February 8, 2024 to November 26, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Symbotic improperly accelerated revenue recognition in its 2024 financial statements; and (2) as a result, defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

DEADLINE: February 3, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/symbotic-loss-submission-form-2/?id=124863&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of SYM during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is February 3, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-symbotic-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-3-2025–sym-302359954.html

SOURCE The Gross Law Firm

January 27, 2025 5:48 am

The Gross Law Firm Notifies Shareholders of Dentsply Sirona Inc.(XRAY) of a Class Action Lawsuit and an Upcoming Deadline

PR Newswire

NEW YORK
, Jan. 27, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Dentsply Sirona Inc. (NASDAQ: XRAY).

Shareholders who purchased shares of XRAY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/dentsply-loss-submission-form/?id=124859&from=4

CLASS PERIOD:
May 6, 2021 to November 6, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Dentsply targeted low-income people who did not have access to good oral hygiene education, a dentist, or dental insurance, which often meant patients signing up for Byte, a DTC aligner solution, had underlying dental issues that would have made them ineligible for treatment; (2) the push for Byte growth and sales commissions caused sales employees to sell to contraindicated patients; (3) as a result of the above, the Byte patient onboarding workflow did not provide adequate assurance that contraindicated patients did not enter treatment; (4) before and during the Class Period, reports of Byte patient injuries were pouring in; (5) Dentsply knew that its Byte aligners were causing severe patient injuries for years but did little to investigate those injuries or notify the FDA; (6) Dentsply had no systems in place to notify the FDA of these injuries, which the Company is required to do within 30 days of learning of a problem; (7) the FDA had received a sharp uptick in reports of serious injuries from Byte patients; (8) as a result of the above, Dentsply materially overstated the goodwill value of Byte; (9) as a result of the above, defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

DEADLINE: January 27, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/dentsply-loss-submission-form/?id=124859&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of XRAY during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is January 27, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-shareholders-of-dentsply-sirona-incxray-of-a-class-action-lawsuit-and-an-upcoming-deadline-302359920.html

SOURCE The Gross Law Firm

January 27, 2025 5:48 am

The Gross Law Firm Reminds Rentokil Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 27, 2025 – RTO

PR Newswire

NEW YORK
, Jan. 27, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Rentokil Initial plc (NYSE: RTO).

Shareholders who purchased shares of RTO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/rentokil-initial-plc-loss-submission-form/?id=124858&from=4

CLASS PERIOD:
December 1, 2023 to September 10, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Rentokil experienced levels of disruption in the early pilots of the Terminix integration; (2) Rentokil experienced significant, ongoing, self-inflicted execution challenges integrating Terminix; (3) the disruption and execution challenges imperiled Rentokil’s integration plan for Terminix; (4) Rentokil and Terminix were still two separate businesses that were not yet integrated; (5) Rentokil’s failure to integrate Terminix negatively impacted the Company’s business and operations, particularly organic revenue growth in North America; and (6) as a result of the above, defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of RTO during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is January 27, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-rentokil-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-27-2025–rto-302359925.html

SOURCE The Gross Law Firm

January 27, 2025 5:48 am

Shareholders that lost money on Revance Therapeutics, Inc.(RVNC) Urged to Join Class Action – Contact The Gross Law Firm to Learn More

PR Newswire

NEW YORK
, Jan. 27, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC).

Shareholders who purchased shares of RVNC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/revance-therapeutics-inc-loss-submission-form-2/?id=124877&from=4

CLASS PERIOD:
February 29, 2024 to December 6, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Revance was in material breach of the Distribution Agreement with Teoxane, which granted Revance “the exclusive right to import, market, promote, sell and distribute Teoxane’s line of dermal fillers; (ii) the foregoing subjected the Company to an increased risk of litigation, as well as monetary and reputational harm; (iii) all the foregoing increased the risk that the tender offer would be delayed and/or amended; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

DEADLINE: March 4, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/revance-therapeutics-inc-loss-submission-form-2/?id=124877&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of RVNC during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 4, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholders-that-lost-money-on-revance-therapeutics-incrvnc-urged-to-join-class-action–contact-the-gross-law-firm-to-learn-more-302360147.html

SOURCE The Gross Law Firm

January 27, 2025 5:48 am

Shareholders that lost money on Five9, Inc.(FIVN) Urged to Join Class Action – Contact The Gross Law Firm to Learn More

PR Newswire

NEW YORK
, Jan. 27, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Five9, Inc. (NASDAQ: FIVN).

Shareholders who purchased shares of FIVN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/five9-inc-loss-submission-form/?id=124864&from=4

CLASS PERIOD:
June 4, 2024 to August 8, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Five9’s net new business was not “strong irrespective of the macro” and was, in fact, hampered by macroeconomic issues such as constrained and scrutinized customer budgets; (ii) Five9 was in the midst of a challenging bookings quarter due, in part, to sales execution and efficiency issues, and the Company was not “seeing very strong bookings momentum”; and (iii) defendants did not have “enough information in terms of [their] existing customers that are going live” such that the statements that Five9 would see a positive inflection in its dollar-based retention rate lacked a reasonable basis.

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of FIVN during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is February 3, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholders-that-lost-money-on-five9-incfivn-urged-to-join-class-action–contact-the-gross-law-firm-to-learn-more-302359932.html

SOURCE The Gross Law Firm

January 27, 2025 5:48 am

The Gross Law Firm Notifies Shareholders of Aehr Test Systems, Inc.(AEHR) of a Class Action Lawsuit and an Upcoming Deadline

PR Newswire

NEW YORK
, Jan. 27, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Aehr Test Systems, Inc. (NASDAQ: AEHR).

Shareholders who purchased shares of AEHR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/aehr-loss-submission-form/?id=124862&from=4

CLASS PERIOD:
January 9, 2024 to March 24, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to prior representations to investors, Aehr was continuing to experience substantial delays in customer orders; (ii) the foregoing issue was likely to have a material negative impact on the Company’s revenue growth; (iii) accordingly, the Company’s business and/or financial prospects were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of AEHR during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is February 3, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-shareholders-of-aehr-test-systems-incaehr-of-a-class-action-lawsuit-and-an-upcoming-deadline-302359936.html

SOURCE The Gross Law Firm

January 27, 2025 5:48 am

The Gross Law Firm Notifies Sun Communities, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – SUI

PR Newswire

NEW YORK
, Jan. 27, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Sun Communities, Inc. (NYSE: SUI).

Shareholders who purchased shares of SUI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/sun-communities-inc-loss-submission-form/?id=124867&from=4

CLASS PERIOD:
February 28, 2019 to September 24, 2024

ALLEGATIONS: According to the complaint, defendants provided investors with material information concerning SUI’s accounting practices and internal control over financial reporting. On September 24, 2024, after market close, an investment research report emerged calling into question the integrity of SUI’s Board and the integrity of the Company’s governance, controls, and financial disclosures. Investors and analysts reacted immediately to SUI’s revelation. The price of SUI’s common stock declined dramatically. From a closing market price of $139.10 per share on September 24, 2024, SUI’s stock price fell to a low of $137.48 per share on September 25, 2024.

DEADLINE: February 10, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/sun-communities-inc-loss-submission-form/?id=124867&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of SUI during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is February 10, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-sun-communities-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline–sui-302359938.html

SOURCE The Gross Law Firm

January 27, 2025 5:48 am

The Gross Law Firm Reminds Customers Bancorp, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 31, 2025 – CUBI

PR Newswire

NEW YORK
, Jan. 27, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Customers Bancorp, Inc. (NYSE: CUBI).

Shareholders who purchased shares of CUBI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/customers-bancorp-inc-loss-submission-form/?id=124860&from=4

CLASS PERIOD:
March 1, 2024 to August 8, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Customers Bancorp had inadequate anti-money laundering practices; (2) as a result, it was not in compliance with its legal obligations, which subjected it to heightened regulatory risk; and (3) as a result, defendants’ statements about Customers Bancorp’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times.

DEADLINE: January 31, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/customers-bancorp-inc-loss-submission-form/?id=124860&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of CUBI during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is January 31, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-customers-bancorp-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-31-2025–cubi-302359923.html

SOURCE The Gross Law Firm

January 27, 2025 5:48 am

Class Action Filed Against MGP Ingredients, Inc. (MGPI) – February 14, 2025 Deadline to Join – Contact The Gross Law Firm

PR Newswire

NEW YORK
, Jan. 27, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of MGP Ingredients, Inc. (NASDAQ: MGPI).

Shareholders who purchased shares of MGPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/mgp-ingredients-inc-loss-submission-form-2/?id=124869&from=4

CLASS PERIOD:
May 4, 2023 to October 30, 2024

ALLEGATIONS: According to the filed complaint, throughout the class period, defendants made materially false and/or misleading statements, and failed to disclose material adverse facts about MGPI’s business, operations, and prospects. Specifically, defendants repeatedly touted a strong demand and “normal” inventory levels in brown goods (i.e., American whiskies and tequila), when in fact there had been a slowdown in consumption and oversupply in their products. Worse, defendants had assured investors that they were positioned differently than their competitors, and that this was a non-issue, because MGPI had already taken steps to mitigate the risk, when in fact it had not.

DEADLINE: February 14, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/mgp-ingredients-inc-loss-submission-form-2/?id=124869&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of MGPI during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is February 14, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/class-action-filed-against-mgp-ingredients-inc-mgpi—february-14-2025-deadline-to-join–contact-the-gross-law-firm-302359953.html

SOURCE The Gross Law Firm